Results 241 to 250 of about 142,419 (302)

Efficacy of Tucidinostat Pre-emptive Therapy for Peripheral T-cell Lymphoma after Allogeneic Stem Cell Transplantation. [PDF]

Intern Med
Takada K, Tachi N, Shonai T, Kawasaki K, Sone T, Ogata H, Kato S, Kobayashi S, Kimura F.   +8 more
europepmc   +1 more source

CD20-positive peripheral T-cell lymphoma not otherwise specified: a case series and review of the literature. [PDF]

Front Oncol
Zhou P, Wang L, Pei X, Yang L, Zhou Y, Ma R, Chen Y, Zhu Z, Yuan X.   +8 more
europepmc   +1 more source

Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter Approach. [PDF]

Mod Pathol
Amador C, Weisenburger DD, Gomez A, Bouska A, Alshomrani A, Alshomrani A, Sharma S, Shah AR, Greiner TC, Vega F, Rosenwald A, Ott G, Feldman AL, Jaffe ES, Ozkaya N, Ondrejka SL, Cook JR, Raess PW, Savage KJ, Slack GW, Song JY, Scott DW, Campo E, Rimsza LM, Khoury JD, Staudt LM, Chan WC, Iqbal J, Leukemia and Lymphoma Molecular Profiling Project Consortium.   +28 more
europepmc   +1 more source

Peripheral T-Cell Lymphoma Mimicking Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids: A Case Report with Confirmatory Brain Biopsy and Longitudinally Extensive Transverse Myelitis. [PDF]

Case Rep Neurol
Shen X, Su N, Zhang L, Zhang Y, Zhao D, Chen Q, Qian H, Yin H, Zhu Y.   +8 more
europepmc   +1 more source

Discrete genetic subtypes and tumor microenvironment signatures correlate with peripheral T-cell lymphoma outcomes. [PDF]

Leukemia
Suehara Y, Sakamoto K, Fujisawa M, Fukumoto K, Abe Y, Makishima K, Suma S, Sakamoto T, Hattori K, Sugio T, Kato K, Akashi K, Matsue K, Narita K, Takeuchi K, Carreras J, Nakamura N, Chiba K, Shiraishi Y, Miyano S, Ogawa S, Chiba S, Sakata-Yanagimoto M.   +22 more
europepmc   +1 more source

The Role of Allogeneic Stem Cell Transplantation in Adult Patients With Peripheral T-Cell Lymphoma: A Systematic Review and Meta-Analysis. [PDF]

Clin Med Insights Oncol
Alazzam A, Said M, AlElaimat M, Alramahi O, Barakat A.   +4 more
europepmc   +1 more source

Real‐world comparison of peripheral neuropathy and treatment delivery between Pola‐R‐CHP and R‐CHOP in DLBCL

British Journal of Haematology, EarlyView.
Nobuhiko Nakamura, Koichi Ohata, Tomohiro Aizaki, Yuto Kaneda, Yoshikazu Ikoma, Takuro Matsumoto, Hiroshi Nakamura, Serika Banno Matsuoka, Shiori Hishida Sadaka, Akio Suzuki, Nobuhiro Kanemura, Masahito Shimizu   +11 more
wiley   +1 more source

Case series of long-term responders to pralatrexate in peripheral T-cell lymphoma. [PDF]

J Clin Exp Hematop
Tomita N, Kitazume K, Kitajima T, Hayata H, Sato S, Nakamura N.   +5 more
europepmc   +1 more source

Aggressive GATA-3 Positive Primary Cutaneous Peripheral T-Cell Lymphoma - Not Otherwise Specified Masquerading as CD-4 Positive Small/Medium T-Cell Lymphoproliferative Disorder: Where is the Line of Delineation?

Indian J Dermatol
Kapetanovic I, Bosic M, Zivanovic D.
europepmc   +1 more source

Plasmacytic markers as immunotherapeutic targets for primary CD20‐negative aggressive B‐cell lymphomas

British Journal of Haematology, EarlyView.
Frank Neumann, Claudia Schormann, Onur Cetin, Igor A. Kos, Moritz Bewarder, Eva C. Schwarz, Stefan Lohse, Stephanie Maurer, Philipp B. Staber, Joerg T. Bittenbring, Sigrun Smola, Konstantinos Christofyllakis, Markus Hoth, Lorenz Thurner   +13 more
wiley   +1 more source